Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation

Published:2012-04-30 Issue:4 Volume:22 Page:302-304
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Med

Author:

Zhidong W.,Hongmin Y.,Hengxiang W.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3148.2012.01156.x/fullpdf

Reference15 articles.

1. Successful resolution of pure red cell aplasia following major ABO-imcompatible unrelated donor stem cell using rituximab: transplantation;Al-Okk;Blood,2003

2. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning;Badros;Transfusion,2002

3. From the bench to the bedside: ways to improve rituximab efficacy;Carton;Blood,2004

4. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation;Deotare;Bone Marrow Transplantation,2006

5. The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann syndrome;Ebihara;International Journal of Hematology,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature;World Journal of Clinical Cases;2024-08-26

2. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab;Transfusion;2024-02-13

3. Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la SFGM-TC;Bulletin du Cancer;2023-02

4. Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation;Journal of Zhejiang University-SCIENCE B;2021-07

5. Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study;British Journal of Haematology;2021-04-12